The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Apogee Therapeutics Inc shares valued at $732,693 were sold by HENDERSON MICHAEL THOMAS on Jan 08 ’25. At $48.85 per share, HENDERSON MICHAEL THOMAS sold 15,000 shares. The insider’s holdings dropped to 1,309,487 shares worth approximately $50.97 million following the completion of this transaction.
Also, HENDERSON MICHAEL THOMAS purchased 15,000 shares, netting a total of over 732,675 in proceeds.
Before that, Dambkowski Carl had sold 4,085 shares from its account. In a trade valued at $191,740, the Chief Medical Officer traded Apogee Therapeutics Inc shares for $46.94 each. Upon closing the transaction, the insider’s holdings decreased to 4,085 shares, worth approximately $9.94 million.
As published in their initiating research note from Canaccord Genuity on November 25, 2024, Apogee Therapeutics Inc [APGE] has been a Buy and the price target has been revised to $89. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early May. As of December 20, 2023, BTIG Research has initiated its “Buy” rating for APGE. Earlier on August 08, 2023, Wedbush initiated its rating. Their recommendation was “an Outperform” for APGE stock.
Analyzing APGE Stock Performance
During the last five days, there has been a drop of approximately -1.07%. Over the course of the year, Apogee Therapeutics Inc shares have dropped approximately -14.08%. Shares of the company reached a 52-week high of $50.56 on 01/07/25 and a 52-week low of $36.48 on 01/16/25. A 50-day SMA is recorded $46.68, while a 200-day SMA reached $48.50. Nevertheless, trading volume fell to 0.6 million shares from 0.6 million shares the previous day.
Support And Resistance Levels for Apogee Therapeutics Inc (APGE)
According to the 24-hour chart, there is a support level at 38.07, which, if violated, would cause prices to drop to 37.22. In the upper region, resistance lies at 40.02. The next price resistance is at 41.12. RSI (Relative Strength Index) is 38.21 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.46, which suggests the price will decrease in the coming days. Percent R is at 82.67%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
